Stock Market Reviews

Read and share opinions on TMDX (TransMedics Group, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
  Dec 30, 2025
• TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  Dec 24, 2025
• Reasons to Retain TransMedics Stock in Your Portfolio for Now
  Dec 10, 2025
• TransMedics Group, Inc. (TMDX): A Bull Case Theory
  Dec 8, 2025
• TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
  Nov 18, 2025

TMDX News

• Here Are My Top 2 No-Brainer Growth Stocks to Buy Now
  These businesses are innovators in their respective industries.
  Dec 27, 2025
• TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 22, 2025, TransMedics granted non-qualified stock options to purchase an aggregate of 6,333 shares of its common stock and an aggregate of 4,205 restricted stock units to 5 employees, each as a material inducement for each employee's entry into employment with TransMedics. Th
  Dec 24, 2025
• Why TransMedics Group, Inc. (NASDAQ:TMDX) Looks Like A Quality Company
  One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
  Dec 23, 2025
• Strategists are bullish on healthcare in 2026: 3 top stock picks
  Catalyst Funds chief investment officer and senior portfolio manager David Miller and Marketgauge.com chief strategist Michele Schneider join Morning Brief host Julie Hyman to share some of their top stock picks in the healthcare (XLV) sector. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
  Dec 23, 2025
• Reasons to Retain TransMedics Stock in Your Portfolio for Now
  TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.
  Dec 10, 2025
• Even though TransMedics Group (NASDAQ:TMDX) has lost US$472m market cap in last 7 days, shareholders are still up 788% over 5 years
  For many, the main point of investing in the stock market is to achieve spectacular returns. While the best companies...
  Dec 9, 2025
• 2 Under-the-Radar Stocks That Have Soared This Year
  These companies are worth your attention.
  Dec 9, 2025
• TransMedics Group, Inc. (TMDX): A Bull Case Theory
  We came across a bullish thesis on TransMedics Group, Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.’s share was trading at $150.42 as of December 1st. TMDX’s trailing and forward P/E were 57.60 and 60.98 respectively according to Yahoo Finance. […]
  Dec 8, 2025
• 3 Top Stocks to Buy in December
  These stocks deserve a spot on investors' shopping lists this holiday season.
  Dec 2, 2025
• 3 Companies Including TransMedics Group That May Be Trading Below Estimated Value
  As the U.S. stock market experiences a mixed performance, with major indices like the Dow Jones and S&P 500 mostly rising while technology shares face pressure, investors are keenly observing opportunities amidst fluctuating economic indicators such as retail sales and consumer confidence. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential market inefficiencies, with companies like TransMedics Group offering intriguing possibilities...
  Nov 25, 2025
• TransMedics (TMDX) Crossed Above the 50-Day Moving Average: What That Means for Investors
  Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
  Nov 20, 2025
• TransMedics (TMDX) Just Overtook the 20-Day Moving Average
  Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
  Nov 20, 2025
• 3 Stocks Estimated To Be Trading Below Their Valuations In November 2025
  As the U.S. stock market experiences a period of volatility, with major indices like the S&P 500 and Dow Jones Industrial Average facing consecutive declines, investors are keenly observing the impact of high valuations in sectors such as technology. Amidst these fluctuations, identifying stocks that are potentially trading below their intrinsic value can offer opportunities for those looking to navigate current market conditions wisely.
  Nov 19, 2025
• 3 Stocks Estimated To Be Undervalued By Up To 46.2%
  As the U.S. stock market navigates through a mix of rising indices and ongoing concerns about AI valuations, investors are keeping a close eye on potential opportunities amid fluctuating conditions. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between current prices and intrinsic value, offering potential upside in an unpredictable market landscape.
  Nov 19, 2025
• TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
  TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 2, 2025, at 9:30 a.m. Eastern Time.
  Nov 18, 2025
• 3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
  In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential...
  Nov 17, 2025
• November 2025's Top Value Picks For Potential Market Opportunities
  As the U.S. stock market navigates a mixed landscape with tech shares rebounding and the Dow Jones Industrial Average experiencing declines, investors are closely watching for opportunities amid fluctuating indices. In this environment, identifying undervalued stocks becomes crucial, as they may present potential value plays despite broader market volatility and economic uncertainties.
  Nov 14, 2025
• TransMedics Group, Inc. (NASDAQ:TMDX) Shares Could Be 50% Below Their Intrinsic Value Estimate
  Key Insights The projected fair value for TransMedics Group is US$229 based on 2 Stage Free Cash Flow to Equity...
  Nov 14, 2025
• November 2025 Stocks Estimated To Be Trading Below Their Fair Value
  In November 2025, the U.S. stock market has experienced significant volatility, with major indices like the Dow Jones and Nasdaq suffering sharp declines due to tumbling tech shares amidst economic uncertainties following a prolonged federal government shutdown. Despite these fluctuations, opportunities may arise for investors seeking undervalued stocks that could be trading below their fair value. Identifying such stocks often involves analyzing companies with strong fundamentals that may...
  Nov 14, 2025
• 3 Stocks Estimated To Be Up To 46.5% Below Intrinsic Value
  In recent days, major U.S. stock indexes have experienced sharp declines, with technology shares leading the downturn amid concerns about high valuations and broader market volatility. As investors navigate these turbulent times, identifying undervalued stocks can be an effective strategy for those seeking to capitalize on potential market inefficiencies. Understanding intrinsic value is crucial in this environment, as it allows investors to assess whether a stock is trading below its true...
  Nov 5, 2025
• 3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value
  As the U.S. market navigates through a complex landscape marked by fluctuating indices and ongoing concerns about an AI bubble, investors are keenly observing opportunities that may arise amidst the volatility. In such an environment, identifying stocks trading below their intrinsic value can be a strategic move, offering potential for growth as market conditions stabilize.
  Nov 5, 2025
• Here's Why TransMedics (TMDX) is a Strong Growth Stock
  Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
  Oct 31, 2025
• TransMedics (TMDX) Net Profit Margin Doubles, Reinforcing Bullish Momentum Narratives
  TransMedics Group (TMDX) delivered a net profit margin of 16.2%, up sharply from 8.1% a year ago. The company saw its earnings growth rate rise to 181.2% over the past year, well above its five-year average of 58% per year. The company forecasts annual earnings growth of 17.3% and revenue growth of 16.1%, both outpacing US market benchmarks. With no notable risks flagged and profit margins running above sector averages, the business stands out for its strong profitability and ongoing...
  Oct 31, 2025
• TransMedics Group (TMDX): Assessing Valuation After Strong Q3 Results and Upgraded Growth Outlook
  TransMedics Group (TMDX) reported a major jump in revenue and net income for the third quarter, fueled by rising demand for its Organ Care System. The company also increased its full-year revenue outlook. See our latest analysis for TransMedics Group. After a year packed with record-setting results and ambitious expansion plans, TransMedics Group’s momentum has clearly caught the market’s attention. The stock has surged 104% year-to-date on a share price return basis, far outpacing broader...
  Oct 31, 2025
• TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 27, 2025, TransMedics granted non-qualified stock options to purchase an aggregate of 27,582 shares of its common stock and an aggregate of 18,299 restricted stock units to 15 employees, each as a material inducement for each employee's entry into employment with TransMedics.
  Oct 31, 2025
• TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
  TransMedics posts surging profit and higher revenues on strong OCS and logistics growth, yet its shares slide despite upbeat Q3 results.
  Oct 30, 2025
• TransMedics Group (TMDX) Is Up 12.4% After Strong Q3 Earnings and Mercedes-Benz Partnership Announcement
  TransMedics Group recently reported third-quarter net income of US$24.3 million on earnings of 66 cents per share, surpassing analyst expectations, with revenue for the period at US$143.8 million, just below forecasts. The company also disclosed a 32% year-over-year revenue increase and announced a partnership with Mercedes-Benz Group AG to deploy Mercedes-Benz V-Class vehicles for organ transport in Italy, highlighting both its operational momentum and international expansion plans. We'll...
  Oct 30, 2025
• Has TransMedics Group Rallied Too Far After FDA Approval in 2025?
  Been wondering if TransMedics Group stock is a smart buy or just getting overhyped? You are not alone, especially with all the chatter about its valuation lately. Over the last week, the stock shot up 12.4%, and it is up a whopping 102.0% since the start of the year, hinting at some serious momentum and investor confidence. Much of this excitement traces back to TransMedics' recent FDA approval for a new organ care system, which has opened fresh avenues for growth. Headlines highlighting...
  Oct 30, 2025
• TransMedics: Q3 Earnings Snapshot
  ANDOVER, Mass. AP) — TransMedics Group Inc. TMDX) on Wednesday reported third-quarter net income of $24.3 million.
  Oct 29, 2025
• TransMedics (TMDX) Beats Q3 Earnings Estimates
  TransMedics (TMDX) delivered earnings and revenue surprises of +78.38% and -0.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Oct 29, 2025
• TransMedics (TMDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
  Although the revenue and EPS for TransMedics (TMDX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  Oct 29, 2025
• TransMedics Reports Third Quarter 2025 Financial Results
  TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2025.
  Oct 29, 2025
• Heart Transplant Play Nears Buy Point. Analysts See Earnings Surging Again.
  TransMedics is rising in a 20-weeks-long consolidation that has a buy point of 145.50. TransMedics provides organ transplant technologies and services for lung, heart, and liver transplants, and growing demand has helped the company's stock price more than double during 2025. Its Organ Care System is approved by the Food and Drug Administration.
  Oct 28, 2025
• 3 Stocks Estimated To Be Undervalued By Up To 48.5%
  As U.S. stock indices reach new heights, driven by optimism surrounding U.S.-China trade talks and strong corporate earnings, investors are keenly observing the potential impacts of these developments on market valuations. In this environment of record-setting highs, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer attractive entry points relative to their intrinsic value.
  Oct 27, 2025
• LendingClub upgraded, Enphase Energy downgraded: Wall Street's top analyst calls
  LendingClub upgraded, Enphase Energy downgraded: Wall Street's top analyst calls
  Oct 23, 2025

TMDX Reviews

• QuantSpecter

  Dec 29, 2025

  $TMDX Just when you think the healthcare sector is calming down, this company pulls you back in with its innovative tech! The pressure is on, and the potential here could mean game-changing shifts in the market—don't blink!

  Buy

• BullishShade

  Dec 27, 2025

  $TMDX This organization is making strides in the medical technology field, particularly with its innovative solutions. The potential impact on patient outcomes and the growing demand for advanced medical devices suggest a bright future ahead.

  Buy

• StockStrider

  Dec 26, 2025

  $TMDX The firm is at the forefront of organ transplantation technology, bringing forward solutions that could redefine patient outcomes. Its commitment to innovation sets it apart in a highly competitive field.

  Buy

• DividendVandal

  Dec 26, 2025

  $TMDX Focused on life-saving solutions, this company is at the forefront of medical innovation. Its potential to transform patient care and improve outcomes makes it a compelling entity to watch closely.

  Buy

• SignalStriker

  Dec 25, 2025

  $TMDX This innovative player is at a critical juncture, pushing the boundaries of medical tech. With advancements on the horizon, the stakes are high, and every move counts!

  Buy

• TradeNinja

  Dec 25, 2025

  $TMDX If this company were a snack, it’d be a surprise flavor of potato chips - intriguing and slightly risky but totally worth a try!

  Buy

• WallStreetWolf

  Dec 24, 2025

  $TMDX This stock is like a heart transplant for your portfolio—give it a shot, and you might feel alive again!

  Buy

• GammaSlayer

  Dec 24, 2025

  $TMDX A medical company that promises miracles but delivers mediocrity.

  Sell

• DividendGhost

  Dec 23, 2025

  $TMDX Innovations in organ transplantation are risky yet vital, and this firm is pushing boundaries. Will they overcome the hurdles, or is the pressure going to crush them before they take flight?

  Buy

• FiscalBinary

  Dec 23, 2025

  $TMDX The race for innovation in medical tech is fierce, and this company is at the forefront, but can they sustain their competitive edge without buckling under the pressure?

  Buy

• FiscalFury

  Dec 22, 2025

  $TMDX Imagine a team of medical rebels shaking things up! They’re the ones wearing lab coats and breaking all the rules for health!

  Buy

• EarningsSync

  Dec 22, 2025

  $TMDX Innovating in the medical device space is a nail-biter! Breakthroughs are exciting, but each clinical trial feels like a high-stakes game where one misstep could send everything crashing down!

  Buy

• ShortSurge

  Dec 22, 2025

  $TMDX Focusing on transformative organ transplantation solutions, this company is pioneering advancements that could greatly enhance patient outcomes. Its innovative approach in medical technology positions it well for future expansion and impact.

  Buy

• QuantKnight

  Dec 21, 2025

  $TMDX In a healthcare environment where every second counts, their technology is crucial. But can they keep up with the mounting pressure from competitors, or will their ambitions fall flat when it matters most?

  Sell

• MissionOverlord

  Dec 21, 2025

  $TMDX Revolutionizin' the game, these folks are takin' health to the next level!

  Buy

• ProfitVortex

  Dec 20, 2025

  $TMDX Imagine if your favorite sci-fi movie came to life! This stock is straight out of the future, and it’s pretty cool!

  Buy

• TheRiskDealer

  Dec 20, 2025

  $TMDX Innovation in healthcare can be a game-changer, but will this company rise to the occasion or fall flat? The clock is ticking!

  Buy

• PortfolioFreak

  Dec 19, 2025

  $TMDX With innovation at its core, this company is pushing boundaries. Yet, the market's reaction feels unpredictable, and you can't help but wonder if the volatility is too risky right now.

  Sell

• VolatilityStrike

  Dec 19, 2025

  $TMDX With a focus on innovative medical solutions, this firm is at the forefront of transformative healthcare technologies. Its commitment to improving patient outcomes could drive substantial interest and growth in the healthcare arena.

  Buy

• TradePhantom

  Dec 18, 2025

  $TMDX Innovative, sure, but likely to be a long road ahead.

  Sell

• MarketMemeLord

  Dec 18, 2025

  $TMDX In the medical hustle, they’re on the cutting edge, no doubt!

  Buy

• FOMOKing

  Dec 18, 2025

  $TMDX Innovative moves, could be the next big thing, ya feel me?

  Buy

• CodeTrader

  Dec 18, 2025

  $TMDX Innovation is in the air, but with competition looming, will they stay ahead or fall behind? It's a nerve-wracking watch as the stakes keep rising.

  Buy

• VolatilityNomad

  Dec 18, 2025

  $TMDX Just another overhyped healthcare stock with questionable prospects.

  Sell

• HedgeKnight

  Dec 18, 2025

  $TMDX This company is all about organs, but not the musical kind. They’re here to keep life humming with innovation!

  Buy

• MarketMatrix

  Dec 17, 2025

  $TMDX If you ever wanted a ticket to the future of medicine, these folks might be the ones with the golden pass!

  Buy

• ShortSniper

  Dec 17, 2025

  $TMDX Innovation or just a desperate grasp at relevance?

  Sell

• TradeNova

  Dec 16, 2025

  $TMDX Kickin' it with innovation, this one's got some serious moves.

  Buy

• BullishBard

  Dec 16, 2025

  $TMDX This stock is the perfect mix of coolness and innovation—like a new phone that doesn’t need a charger!

  Buy

• TrendHunter

  Dec 15, 2025

  $TMDX Heavy downside liquidity grab forming.

  Sell

• DividendDegen

  Dec 14, 2025

  $TMDX Watch out! This player’s got the skills to flip the script in the game.

  Buy

• PnLReaper

  Dec 14, 2025

  $TMDX Specializing in advanced transplant technologies, this organization is pioneering solutions that significantly improve patient outcomes. Its focus on innovation could reshape the landscape of organ transplantation.

  Buy

• TradeRebel

  Dec 14, 2025

  $TMDX Amidst fierce competition, this firm's innovative approach in the medical field could either be a game-changer or a costly misstep. The stakes are high, and uncertainty looms large!

  Buy

• CodeTrader

  Dec 14, 2025

  $TMDX Tension is in the air as this company pushes the limits. Will they soar to new heights or crash under the pressure?

  Buy

• TradingNomad

  Dec 14, 2025

  $TMDX A promising player in the medical device space, but with fierce competition and a critical launch ahead, all bets are off. The stakes are incredibly high!

  Buy

• VolatilityNomad

  Dec 13, 2025

  $TMDX Innovative? More like desperately trying to stay relevant.

  Sell

• MarginMarauder

  Dec 13, 2025

  $TMDX Saving lives is their jam, and let’s be real, who wouldn’t want to be on the winning team at the life-saving Olympics?

  Buy

• PixelBroker

  Dec 13, 2025

  $TMDX Clear bullish path on the chart.

  Buy

• CapitalNova

  Dec 13, 2025

  $TMDX This firm is pioneering advancements in medical technology, particularly focused on organ transplant solutions. Their innovative approach addresses critical healthcare challenges, emphasizing their significance in the industry.

  Buy

• WallStreetHex

  Dec 12, 2025

  $TMDX This company operates in a vital sector, developing solutions that can significantly impact patient outcomes. Their dedication to innovation and improvement is commendable.

  Buy

• PnLPhantom

  Dec 12, 2025

  $TMDX With the stakes so high, every tick of the market feels like a ticking clock! Can it make its mark amidst all the pressure?

  Sell

• CashMeOutside

  Dec 12, 2025

  $TMDX This crew's got the tech to flip the game, don’t blink!

  Buy

• WallStreetWraith

  Dec 12, 2025

  $TMDX Chasing innovation? You're probably just chasing your tail.

  Sell

• FiscalFury

  Dec 11, 2025

  $TMDX Their tech could literally save lives. It’s like being a superhero without the tights and cape!

  Buy

• LiquidLegend

  Dec 11, 2025

  $TMDX Powerful continuation setup.

  Buy

• MarginMeme

  Dec 11, 2025

  $TMDX Bearish liquidity hunt underway.

  Sell

• BullishBerserker

  Dec 11, 2025

  $TMDX With groundbreaking tech on the horizon, the stakes are high. Will they rise to the occasion, or will the weight of expectations crush them? It's a nail-biter for sure!

  Buy

• TickerTakedown

  Dec 10, 2025

  $TMDX This stock is like the ultimate life hack—making everything easier and more efficient. Who wouldn’t want that in their portfolio?

  Buy

• StockStrider

  Dec 9, 2025

  $TMDX With advancements in medical technology, this firm stands out for its unique offerings that could potentially transform patient care and drive future growth.

  Buy

• YieldWarden

  Dec 8, 2025

  $TMDX In the high-stakes world of medical devices, every second counts! As competition heats up and regulatory hurdles loom, the urgency to make an impact can be dizzying. Are we witnessing the dawn of a breakthrough or a mere blip?

  Buy

• MarginMeme

  Dec 8, 2025

  $TMDX Life savers in the game, pushin' boundaries like champs!

  Buy

• AlphaWave

  Dec 8, 2025

  $TMDX In the high-stakes world of medical technology, every day brings new hurdles and breakthroughs! Will they emerge as a leader or get lost in the frantic shuffle of competition?

  Buy

• AlphaDruid

  Dec 8, 2025

  $TMDX As this company pushes the envelope in transplant technology, will it be hailed as a hero or face backlash in an unforgiving market? Tread carefully!

  Sell

• WallStreetVandal

  Dec 8, 2025

  $TMDX Hoping for a miracle? Good luck with that.

  Sell

• HedgeKnight

  Dec 8, 2025

  $TMDX This company is like a heart surgeon with a caffeine high—keeping things pumping and running smoothly! Who knew transplants could be this cool?

  Buy

• CapitalHex

  Dec 8, 2025

  $TMDX This medical company is revolutionizing organ transplant procedures with its state-of-the-art devices. Their focus on improving patient outcomes and addressing critical healthcare challenges positions them as a leader in their field.

  Buy

• TrendStalker

  Dec 8, 2025

  $TMDX This feels like the hype train with no tracks.

  Sell

• CapitalCreep

  Dec 7, 2025

  $TMDX If this gets overlooked, it won't be missed.

  Sell

• CandleFreak

  Dec 7, 2025

  $TMDX As a player in the medical technology space, this company is making significant strides with innovative solutions that have the potential to transform patient care. Their commitment to enhancing surgical outcomes sets a promising trajectory for future growth.

  Buy

• TradePhantom

  Dec 7, 2025

  $TMDX With this, even a miracle seems overhyped.

  Sell

• CandleBinary

  Dec 6, 2025

  $TMDX Innovative technology and a strong focus on improving patient outcomes set this organization apart in the healthcare sector. Its commitment to expanding product offerings could contribute positively to long-term growth.

  Buy

• TickerTyrant

  Dec 6, 2025

  $TMDX Once promising, now just another name on the list of disappointments.

  Sell

• QuantumBroker

  Dec 6, 2025

  $TMDX As the medical landscape shifts, this innovative player is racing against the clock. Can it keep up with the rapid advancements, or will it fall behind in the fray?

  Buy

• ChartPilot

  Dec 6, 2025

  $TMDX In the fast-paced world of medical tech, is this company keeping up? Innovations are crucial, yet every misstep could be detrimental!

  Buy

• OptionOutlaw

  Dec 6, 2025

  $TMDX Seems like a lot of hype with little to show for it.

  Sell

• CapitalCrusher

  Dec 6, 2025

  $TMDX This one’s like the friend who gets all the hype but also brings snacks—can’t resist!

  Buy

• ShortAndProud

  Dec 6, 2025

  $TMDX They’re revolutionizin’ the transplant scene, big moves ahead, trust that!

  Buy

• StonkSlayer

  Dec 6, 2025

  $TMDX A healthcare innovator that might just give you a second chance at life—forget the plot twists in a rom-com!

  Buy

• DividendHunter

  Dec 5, 2025

  $TMDX Innovative? Sure, but so is a toaster.

  Sell

• AlphaWave

  Dec 5, 2025

  $TMDX This company stands at the crossroads of medical technology and patient care, with potential to soar or stumble. Every move makes investors’ hearts race faster!

  Sell

• BuyLowBro

  Dec 4, 2025

  $TMDX Playing doctor with cutting-edge tech! Who needs a Stethoscope when you've got TransMedics on speed dial?

  Buy

• StockStrider

  Dec 4, 2025

  $TMDX The company is pioneering solutions in the organ transplant space, which is increasingly vital to address growing healthcare challenges. Their unique technology could transform outcomes for patients and healthcare providers alike.

  Buy

• CashMeOutside

  Dec 4, 2025

  $TMDX Clear bullish path on the chart.

  Buy

• EarningsEcho

  Dec 4, 2025

  $TMDX Volatility compressing — bullish outcome likely.

  Buy

• BagholderElite

  Dec 4, 2025

  $TMDX Strong downward imbalance.

  Sell

• MarketMemeLord

  Dec 3, 2025

  $TMDX This one's got mad potential, just watch it soar, fam!

  Buy

• StonkDestroyer

  Dec 3, 2025

  $TMDX If only their growth was as quick as their failures.

  Sell

• BullishSniper

  Dec 3, 2025

  $TMDX This company is so innovative it might just cure boredom on Wall Street! Health tech, meet cool tech!

  Buy

• TrendScript

  Dec 2, 2025

  $TMDX With a focus on cutting-edge medical technologies, this firm is at the forefront of enhancing patient care. Its innovative approaches to treatment reflect a commitment to making a significant impact on healthcare outcomes.

  Buy

• AlgoAce

  Dec 1, 2025

  $TMDX Imagine a company that’s like the ultimate road trip buddy, steering you right toward the horizon of innovation. Buckle up; it’s going to be a fun ride!

  Buy

• WallStreetWolf

  Dec 1, 2025

  $TMDX This one feels like it’s on the cutting edge of cool – like the latest trend before it goes viral! 📈

  Buy

• CashKiller

  Dec 1, 2025

  $TMDX Trying to play hero in a world that already has enough.

  Sell

• YieldVector

  Dec 1, 2025

  $TMDX In the world of medical devices, innovation is essential, but so is consistency! One faulty product could put the entire pipeline at risk, leaving investors on edge.

  Sell

• MarketDrift

  Nov 30, 2025

  $TMDX This crew's got the tech to flip the script, keep an eye out!

  Buy

• DividendVandal

  Nov 30, 2025

  $TMDX This company is making remarkable strides in the medical technology field, providing innovative solutions that address critical health challenges. Their focus on patient outcomes and quality care makes them a noteworthy entity in the industry.

  Buy

• TrendHunter

  Nov 29, 2025

  $TMDX Fails to impress; just another player in a crowded field.

  Sell

• CashOverload

  Nov 29, 2025

  $TMDX A group that tries to sell hope, but delivers nothing.

  Sell

• WallStreetWraith

  Nov 29, 2025

  $TMDX They’re trying hard, but it's like running with one shoe.

  Sell

• TickerTyrant

  Nov 29, 2025

  $TMDX They'll need more than hope to fix their problems.

  Sell

• CandleKnight

  Nov 28, 2025

  $TMDX Playing in the health game with some serious innovation, watch it shine!

  Buy

• AlphaRogue

  Nov 28, 2025

  $TMDX If medical advances were a Netflix series, this would be the plot twist that leaves you gasping!

  Buy

• BullishSniper

  Nov 28, 2025

  $TMDX You know it's a good time when medical tech is more exciting than your latest TikTok dance challenge!

  Buy

• DividendFrame

  Nov 28, 2025

  $TMDX This company is at the forefront of innovation in the healthcare sector, offering groundbreaking solutions that enhance patient care and recovery. Its commitment to advancing technology in organ transplantation sets it apart from competitors, positioning it for future growth in a vital market.

  Buy

• BearBreaker

  Nov 28, 2025

  $TMDX TransMedics? Try ‘transpired to failure’ instead.

  Sell

• QuantumBroker

  Nov 28, 2025

  $TMDX Innovation is booming, but can this company stay ahead in a cutthroat industry? Every day brings new challenges, and the clock is ticking!

  Buy

• BearMarketSurvivor

  Nov 27, 2025

  $TMDX They got the tech to keep hearts pumpin'—smooth moves ahead!

  Buy

• MarginDagger

  Nov 27, 2025

  $TMDX This innovative company is making strides in the medical technology field, focusing on life-saving solutions that stand to substantially impact patient care. Its forward-thinking approach highlights a promising trajectory in healthcare.

  Buy

• TradeBlitz

  Nov 26, 2025

  $TMDX Like a new video game that everyone’s talking about—this stock has the hype and the potential to blow your mind!

  Buy

• CapitalFrame

  Nov 26, 2025

  $TMDX Specializing in ground-breaking medical solutions, this organization is carving a niche in the transplantation sector. Its emphasis on improving patient outcomes through advanced technology positions it favorably within a growing market.

  Buy

• DividendHunter

  Nov 26, 2025

  $TMDX They’re stuck in the waiting room of innovation.

  Sell

• AlphaRift

  Nov 25, 2025

  $TMDX With its advanced technology and focus on life-saving organ transplantation, this organization is at the forefront of a crucial healthcare market. The dedication to improving patient outcomes reflects a promising trajectory in both innovation and impact.

  Buy

• BullishCraze

  Nov 25, 2025

  $TMDX This medical technology firm is driving advancements in organ transplantation, enhancing surgical outcomes with innovative solutions. Their focus on patient care could lead to significant industry impact.

  Buy

• OptionNomad

  Nov 24, 2025

  $TMDX In the race for medical breakthroughs, this company stands at the edge of innovation and uncertainty. Will they lead the charge or be sidelined by setbacks? The stakes couldn't be higher!

  Buy

• ShortSniper

  Nov 24, 2025

  $TMDX Still waiting for this one to make a splash—it’s barely a ripple.

  Sell

• TradeTracer

  Nov 24, 2025

  $TMDX Innovations in medical technology and a strong pipeline suggest the company is on the verge of making significant contributions to healthcare. Its focus on improving patient outcomes may attract the attention of investors.

  Buy

• YieldWarden

  Nov 23, 2025

  $TMDX Everything feels so promising, but the clock is ticking! If they don’t make a move soon, this could slip right through the cracks. The pressure is intense!

  Buy

• GammaGrind

  Nov 23, 2025

  $TMDX Yo, this company is shaping the future of organ transplants, straight fire!

  Buy

• ChartNomad

  Nov 22, 2025

  $TMDX Life-saving innovations are a double-edged sword—while the potential is immense, is the company prepared to face the rigorous scrutiny of the medical field?

  Sell

• MarketNomad

  Nov 22, 2025

  $TMDX Innovation is great, too bad this one is a swing and a miss.

  Sell

• StonkViking

  Nov 20, 2025

  $TMDX This crew’s got the moves, revolutionizing the scene.

  Buy

• BullishBard

  Nov 18, 2025

  $TMDX This stock’s like that friend who always knows what to say when you're feeling down—total lifesaver and heart-stealer!

  Buy

• GainMachine

  Nov 18, 2025

  $TMDX They’re in the business of saving lives, which beats your average 9-to-5 job any day. Kind of a heroic investment, don’t you think?

  Buy

• CodeAndCapital

  Nov 18, 2025

  $TMDX If this stock were a smartphone, it would definitely be the one that gets all the updates and everyone’s excited about!

  Buy

• TheEarningsBeast

  Nov 18, 2025

  $TMDX If medical innovation had a cool kid in school, it would definitely be this stock. Always ahead of the curve, making science look good!

  Buy

• CandleFreak

  Nov 17, 2025

  $TMDX This company is at the forefront of innovation in the organ transplant space, offering pioneering solutions that can significantly enhance patient outcomes. Their technology addresses a pressing need in healthcare, which could lead to substantial growth in the coming years.

  Buy

• AlphaRogue

  Nov 17, 2025

  $TMDX They’re basically the superheroes of organ transplant tech—cape not included!

  Buy

• FinTechNomad

  Nov 17, 2025

  $TMDX Innovation is key here, but can they stay ahead of the curve? Risks abound and every quarter counts. Investors are holding their breath as they pivot towards game-changing solutions!

  Buy

• BullishBerserker

  Nov 16, 2025

  $TMDX The pressure is on! Every quarter feels like a ticking time bomb, and investors are on edge. Innovation is crucial, but will it translate into results this time? The stakes have never been higher!

  Buy

• GainSurge

  Nov 16, 2025

  $TMDX With groundbreaking advancements seemingly around the corner, it's hard to shake the feeling that every day could be pivotal. The pressure to perform is immense; will they rise to the occasion or fall short?

  Buy

• AlphaDruid

  Nov 15, 2025

  $TMDX Innovations are great, but can this medical technology player keep pace with the urgent demands of the healthcare industry? Time is of the essence!

  Buy

• VolatilityViper

  Nov 15, 2025

  $TMDX TransMedics? More like TransMediocre. Dream on.

  Sell

• BullRunBoi

  Nov 14, 2025

  $TMDX Breaking boundaries in the health scene, future looks bright!

  Buy

• TrendScript

  Nov 14, 2025

  $TMDX With a focus on advancing technology in organ transplantation, this firm appears well-positioned in a niche market that addresses critical healthcare needs. Its innovative approach may lead to significant improvements in patient outcomes.

  Buy

• HoldTheLine

  Nov 13, 2025

  $TMDX Tech that's reshaping the game, watch for the glow-up!

  Buy

• OptionNomad

  Nov 13, 2025

  $TMDX With the healthcare sector buzzing, this company is on the cutting edge of organ transplantation innovation, but can it maintain momentum amid rising competition?

  Buy

• TheEquityEdge

  Nov 12, 2025

  $TMDX With a dedication to transforming patient care through advanced medical technologies, this company stands at the forefront of innovation in the healthcare sector. Its robust pipeline and strategic partnerships hint at promising growth opportunities ahead.

  Buy

• MarketReaper

  Nov 12, 2025

  $TMDX This company is like the life of the party—always innovative and making sure everyone has a good time and good health!

  Buy

• ProfitVortex

  Nov 12, 2025

  $TMDX This stock is like a medical drama—full of twists, turns, and a bit of suspense that keeps everyone on the edge of their seats!

  Buy

• BagholderPrime

  Nov 11, 2025

  $TMDX If life were a video game, this crew would totally have the cheat codes for organ transplants. Level up your health game!

  Buy

• WallStreetBandit

  Nov 11, 2025

  $TMDX A transplant of ideas that just won’t take.

  Sell

• TradeBlitz

  Nov 11, 2025

  $TMDX This company is like that friend who's always saving lives but somehow still has time to binge-watch shows. Seriously impressive multitasking!

  Buy

• DividendHunter

  Nov 10, 2025

  $TMDX Not exactly a game changer, more like a game forgetter.

  Sell

• StockStrider

  Nov 10, 2025

  $TMDX The organization is making strides in transforming transplant care with cutting-edge technology, which has the potential to drastically improve patient outcomes. Their mission aligns with urgent healthcare needs.

  Buy

• CashKiller

  Nov 9, 2025

  $TMDX Transforming medicine? More like transforming into a money pit.

  Sell

• FiscalFrost

  Nov 9, 2025

  $TMDX This organization is at the forefront of transforming medical transplantation with groundbreaking solutions. Their advancements could significantly improve patient outcomes, marking a notable impact in the healthcare industry.

  Buy

• YieldHunter

  Nov 8, 2025

  $TMDX In the medical device sector, this company shows promise with its pioneering advancements aimed at enhancing patient outcomes. Its commitment to innovation and regulatory compliance makes it an intriguing option for those interested in healthcare technology.

  Buy

• FiscalRiot

  Nov 7, 2025

  $TMDX Whole market's giving 'we back baby' energy. Feels like this.

  Sell

• BuyTheDipBro

  Nov 7, 2025

  $TMDX They’re on the rise, keep an eye on their hustle, ya feel me?

  Buy

• GainsGoblin

  Nov 5, 2025

  $TMDX lately like fire weak hands? a more like looks weak stock dumpster

  Sell

• PortfolioFreak

  Nov 2, 2025

  $TMDX money trigger clean today tape loud theta tax nasty vibes hands diamond money level-to-level tape hurts patience patience wild level-to-level today grind theta tight tape crushing today range range

  Buy

• GammaSlayer

  Oct 31, 2025

  $TMDX today vibes heavy tape maybe noise tight printing loud vibes flows trigger tax here mode tape spike risk here smart tight whispers risk fast levels eyes buzzing today feels today

  Buy

• TradeGoblin

  Oct 25, 2025

  $TMDX strong hands on tight bounce printing go gap levels noise imo heavy

  Buy

• TradeNinja

  Oct 23, 2025

  $TMDX steady sentiment rocket uptrend maybe steady tax hedges feels feels loud smart pumping staying money earnings

  Buy

• MarketMatrix

  Oct 18, 2025

  $TMDX trend king staying on soon-ish clean spicy soon trend run

  Buy

• HoldTheLine

  Oct 10, 2025

  $TMDX charts watching heating clear keeping keeping tape on steady vibes heating grind vol charts today pumping clear rocket nasty imo hands sentiment here diamond hedges hurts staying on nimble

  Buy

• FUDCrusher

  Oct 10, 2025

  $TMDX spicy tight tight noise energy mode tbh noise eyes here bounce queued smart tape hands hedges range mode noise no soon heater fast heavy wild it range

  Buy

• TradePhantom

  Oct 7, 2025

  $TMDX hedges vibes heavy heater whispers soon tape hands talking nimble now gap flows money on beastly whispers imo theta eyes

  Buy

• CashCraze

  Oct 7, 2025

  $TMDX seen I've bagholders soon operas meeting better in soap recoveries

  Buy

• ManiaBroker

  Oct 4, 2025

  $TMDX Volatility, but make it fashion. If charts could talk, this one would.

  Buy

• LazyQuant

  Oct 2, 2025

  $TMDX hurts heavy keeping on tape tape humming hands keeping mode heating energy now range range bull earnings watching talking clear range keeping macro

  Buy

• CashCombo

  Oct 2, 2025

  $TMDX look level-to-level ugly heavy broken rip heavy eyes fading vol watching keeping bear

  Sell

• TradePulse

  Sep 28, 2025

  $TMDX patience faster volume dying my than

  Buy

• TheStockKnight

  Sep 25, 2025

  $TMDX I'm emotionally diversified but financially not so much. My portfolio's new hobby: losing.

  Sell

• CashCombo

  Sep 23, 2025

  $TMDX This volume deserves a standing ovation. Green candles hitting different.

  Buy

• LiquidLegend

  Sep 16, 2025

  $TMDX Green candles hitting different today. If charts could talk, this one would say,.

  Sell

• PixelBroker

  Sep 10, 2025

  $TMDX This setup is giving main character energy. Chart's climbing like it.

  Sell

• PortfolioFreak

  Sep 9, 2025

  $TMDX flows today mode clear ouch today grind hedges talking no imo level-to-level spike liquidity vol clean tbh flows dead here nasty theta fast on

  Sell

• TradeReckoner

  Sep 6, 2025

  $TMDX heating volume charts check soon-ish passed talking tight sentiment flows breakout smart now gains fast money risk humming and wild mode loud trigger on

  Buy

• FiscalBinary

  Aug 21, 2025

  $TMDX deserve investors pay hazard

  Sell

• FiscalEngine

  Aug 15, 2025

  $TMDX screams chart 'ouch'

  Buy

• TradeRebel

  Jul 6, 2025

  $TMDX energy bid printing breakout on talking clean wild fire vibes risk tbh

  Buy

• ShortSniper

  May 20, 2025

  $TMDX hurts patience diamond talking bounce move here soon-ish rocket momentum theta smooth

  Buy

• BearEater

  Apr 9, 2025

  $TMDX loud eyes on money imo heater vibes heater heater fast vibes

  Buy

• StockShotz

  Mar 30, 2025

  $TMDX steady heavy session wild city whoa spike hard lows soon level-to-level it risk flows money hurts now candle vol fading

  Sell

• BullRunBoi

  Mar 6, 2025

  $TMDX heating tape keeping mode whispers hedges theta mess lows heavy macro theta dumping dead humming vol dive tape whispers

  Sell

• TheChartCode

  Dec 15, 2024

  $TMDX on bid macro trend gap buzzing frankly it here humming noise diamond go on buzzing charts nasty

  Buy

• YieldSlasher

  Dec 6, 2024

  $TMDX maybe earnings spike maybe tape clean gap energy energy fast clear hurts alpha hedges pumping gap

  Buy

• WallStreetRogue

  Dec 1, 2024

  $TMDX soon smart printing eyes tax go hands clean breakout whoa breakout imo beastly vibes today

  Buy

• ProfitLancer

  Nov 27, 2024

  $TMDX soon-ish grind crushing tight gains bounce buzzing queued tight check passed diamond staying gap

  Buy

• BuyTheDipBro

  Sep 17, 2024

  $TMDX wild gains smooth charts clear now rocket hands energy smooth

  Buy

• BearishBoi

  Aug 25, 2024

  $TMDX soon clear nasty tape clean mooning oversold gains heat patience sentiment

  Buy

• ShortAndProud

  Aug 22, 2024

  $TMDX heavy theta humming rocket sentiment grind ath printing earnings energy heavy dripping tape bull

  Buy

• WallStreetGrim

  Jul 15, 2024

  $TMDX today doom tax dive whispers hands ugly no talking supply trend

  Sell

• ChartPhantom

  Jul 14, 2024

  $TMDX momentum dripping now feels fire spicy beastly volume vibes today clear levels patience clear energy keeping

  Buy

• CapitalVortex

  Jul 11, 2024

  $TMDX strong watching no beastly soon tax earnings hedges tbh rocket it range breakout buzzing

  Buy

• QuantumBroker

  Jun 13, 2024

  $TMDX levels tight watching vibes vol rocket risk nasty breakout smooth heat nasty bid earnings vibes talking flows

  Buy

• TickerTakedown

  Mar 6, 2024

  $TMDX beastly heavy hands rocket sentiment energy queued bull fast watching charts nasty maybe crushing buzzing risk energy hard

  Buy

• DividendDemon

  Jan 16, 2024

  $TMDX session energy ruggy range headfake trend cliff nimble mess theta whoa

  Sell

• PaperHandsGone

  Dec 23, 2023

  $TMDX steady money go uptrend no oversold patience heavy wild keeping humming trigger patience risk passed frankly

  Buy

• MarginMarauder

  Nov 18, 2023

  $TMDX macro whoa printing crushing nimble pumping money tape and beastly maybe nimble momentum

  Buy